Viral appropriation of apoptotic and NF‐κB signaling pathways

Viruses utilize a variety of strategies to evade the host immune response and replicate in the cells they infect. The comparatively large genomes of the Orthopoxviruses and gammaherpesviruses encode several immunomodulatory proteins that are homologous to component of the innate immune system of host cells, which are reviewed here. However, the viral mechanisms used to survive host responses are quite distinct between these two virus families. Poxviruses undergo continuous lytic replication in the host cytoplasm while expressing many genes that inhibit innate immune responses. In contrast, herpesviruses persist in a latent state during much of their lifecycle while expressing only a limited number of relatively non‐immunogenic viral proteins, thereby avoiding the adaptive immune response. Poxviruses suppress, whereas latent gammaherpesviruses activate, signaling by NF‐κB, yet both viruses target similar host signaling pathways to suppress the apoptotic response. Here, modulation of apoptotic and NF‐κB signal transduction pathways are examined as examples of common pathways appropriated in contrasting ways by herpesviruses and poxviruses. © 2004 Wiley‐Liss, Inc.

[1]  Daniel R. Caffrey,et al.  LPS-TLR4 Signaling to IRF-3/7 and NF-κB Involves the Toll Adapters TRAM and TRIF , 2003, The Journal of experimental medicine.

[2]  S. Howell,et al.  KSHV vFLIP binds to IKK-γ to activate IKK , 2003, Journal of Cell Science.

[3]  S. Ross,et al.  Viruses and Toll-like receptors. , 2003, Microbes and infection.

[4]  Jiahuai Han,et al.  Identification of Lps2 as a key transducer of MyD88-independent TIR signalling , 2003, Nature.

[5]  R. Sun,et al.  NF-κB Inhibits Gammaherpesvirus Lytic Replication , 2003, Journal of Virology.

[6]  G. McFadden,et al.  Poxvirus Immunomodulatory Strategies: Current Perspectives , 2003, Journal of Virology.

[7]  C. Fielding,et al.  Latent Membrane Protein 1 Inhibits Epstein-Barr Virus Lytic Cycle Induction and Progress via Different Mechanisms , 2003, Journal of Virology.

[8]  I. Haga,et al.  The Poxvirus Protein A52R Targets Toll-like Receptor Signaling Complexes to Suppress Host Defense , 2003, The Journal of experimental medicine.

[9]  Sophie Janssens,et al.  Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. , 2003, Molecular cell.

[10]  T. Akazawa,et al.  TICAM-1, an adaptor molecule that participates in Toll-like receptor 3–mediated interferon-β induction , 2003, Nature Immunology.

[11]  I. Mohr,et al.  Identification of a Lytic-Cycle Epstein-Barr Virus Gene Product That Can Regulate PKR Activation , 2003, Journal of Virology.

[12]  S. Akira,et al.  Cutting Edge: A Novel Toll/IL-1 Receptor Domain-Containing Adapter That Preferentially Activates the IFN-β Promoter in the Toll-Like Receptor Signaling1 , 2002, The Journal of Immunology.

[13]  G. McFadden,et al.  The Myxoma Poxvirus Protein, M11L, Prevents Apoptosis by Direct Interaction with the Mitochondrial Permeability Transition Pore , 2002, The Journal of experimental medicine.

[14]  L. Kirshenbaum,et al.  IKKβ Is Required for Bcl-2-mediated NF-κB Activation in Ventricular Myocytes* , 2002, The Journal of Biological Chemistry.

[15]  D. Green,et al.  The Lymphotoxin-β Receptor Induces Different Patterns of Gene Expression via Two NF-κB Pathways , 2002 .

[16]  M. Stanley,et al.  Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential , 2002, Clinical and experimental dermatology.

[17]  J. Langland,et al.  The role of the PKR-inhibitory genes, E3L and K3L, in determining vaccinia virus host range. , 2002, Virology.

[18]  T. Hofmann,et al.  The Human Papillomavirus Oncoprotein E7 Attenuates NF-κB Activation by Targeting the IκB Kinase Complex* , 2002, The Journal of Biological Chemistry.

[19]  J. Panus,et al.  Cowpox virus encodes a fifth member of the tumor necrosis factor receptor family: A soluble, secreted CD30 homologue , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[20]  B. Williams,et al.  Blockade of Interferon Induction and Action by the E3L Double-Stranded RNA Binding Proteins of Vaccinia Virus , 2002, Journal of Virology.

[21]  D. Bellows,et al.  Epstein-Barr Virus BALF1 Is a BCL-2-Like Antagonist of the Herpesvirus Antiapoptotic BCL-2 Proteins , 2002, Journal of Virology.

[22]  Geoffrey L. Smith,et al.  Vaccinia virus CrmE encodes a soluble and cell surface tumor necrosis factor receptor that contributes to virus virulence. , 2002, Virology.

[23]  F. Osorio,et al.  The Genome of Swinepox Virus , 2002, Journal of Virology.

[24]  M. Esteban,et al.  MC159L protein from the poxvirus molluscum contagiosum virus inhibits NF-kappaB activation and apoptosis induced by PKR. , 2001, The Journal of general virology.

[25]  R. Flavell,et al.  Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.

[26]  C. Benedict,et al.  Virus targeting of the tumor necrosis factor superfamily. , 2001, Virology.

[27]  D. Pickup,et al.  Cowpox virus and other members of the orthopoxvirus genus interfere with the regulation of NF-kappaB activation. , 2001, Virology.

[28]  S. Swain,et al.  Interleukin 18 , 2001, The Journal of experimental medicine.

[29]  A. Alcamí,et al.  The Vaccinia Virus Soluble Alpha/Beta Interferon (IFN) Receptor Binds to the Cell Surface and Protects Cells from the Antiviral Effects of IFN , 2000, Journal of Virology.

[30]  T. Wirth,et al.  NF-κB transcription factors: critical regulators of hematopoiesis and neuronal survival , 2000 .

[31]  D. Greaves,et al.  Mechanism of inactivation of NF-kappa B by a viral homologue of I kappa b alpha. Signal-induced release of i kappa b alpha results in binding of the viral homologue to NF-kappa B. , 2000, The Journal of biological chemistry.

[32]  E. Harhaj,et al.  Domain-specific Interaction with the IκB Kinase (IKK) Regulatory Subunit IKKγ Is an Essential Step in Tax-mediated Activation of IKK* , 2000, The Journal of Biological Chemistry.

[33]  J. Sample,et al.  Epstein-Barr Virus Small RNAs Potentiate Tumorigenicity of Burkitt Lymphoma Cells Independently of an Effect on Apoptosis , 2000, Journal of Virology.

[34]  S. Akira,et al.  The role of Toll-like receptors and MyD88 in innate immune responses , 2000, Journal of endotoxin research.

[35]  E. Cesarman,et al.  Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. , 2000, Blood.

[36]  A. Bowie,et al.  A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Y. Lazebnik,et al.  Antiapoptotic Herpesvirus Bcl-2 Homologs Escape Caspase-Mediated Conversion to Proapoptotic Proteins , 2000, Journal of Virology.

[38]  M. Horwitz,et al.  Regulation of the NF-κB Activation Pathway by Isolated Domains of FIP3/IKKγ, a Component of the IκB-α Kinase Complex* , 2000, The Journal of Biological Chemistry.

[39]  S. Maruo,et al.  Oncogenic Role of Epstein-Barr Virus-Encoded RNAs in Burkitt’s Lymphoma Cell Line Akata , 1999, Journal of Virology.

[40]  R. Flavell,et al.  Lymphotoxin-β-deficient mice show defective antiviral immunity , 1999 .

[41]  T. Graf,et al.  Epstein-Barr Virus Encodes a Novel Homolog of the bcl-2 Oncogene That Inhibits Apoptosis and Associates with Bax and Bak , 1999, Journal of Virology.

[42]  J. Sample,et al.  Epstein-Barr Virus Regulates c-MYC, Apoptosis, and Tumorigenicity in Burkitt Lymphoma , 1999, Molecular and Cellular Biology.

[43]  D. Faller,et al.  Arginine butyrate-induced susceptibility to ganciclovir in an Epstein-Barr-virus-associated lymphoma. , 1998, Blood cells, molecules & diseases.

[44]  Rouse Bt,et al.  A skeptical look at viral immune evasion. , 1997 .

[45]  A Ciechanover,et al.  Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[46]  M. Jäättelä,et al.  The ability of BHRF1 to inhibit apoptosis is dependent on stimulus and cell type , 1997, Journal of virology.

[47]  G M Cohen,et al.  Caspases: the executioners of apoptosis. , 1997, The Biochemical journal.

[48]  J. Tschopp,et al.  Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors , 1997, Nature.

[49]  J. Russo,et al.  Kaposi's sarcoma-associated herpesvirus encodes a functional Bcl-2 homologue , 1997, Nature Medicine.

[50]  A. Alcamí,et al.  A mechanism for the inhibition of fever by a virus. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[51]  S. Der,et al.  Involvement of the double-stranded-RNA-dependent kinase PKR in interferon expression and interferon-mediated antiviral activity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[52]  C. Ware,et al.  The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family , 1995, Cell.

[53]  P. Hershberger,et al.  The apoptotic suppressor P35 is required early during baculovirus replication and is targeted to the cytosol of infected cells , 1994, Journal of virology.

[54]  Z. Oltvai,et al.  BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax , 1994, Nature.

[55]  M. Rowe,et al.  Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[56]  R. Black,et al.  Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme , 1992, Cell.

[57]  C. Dinarello Interleukin-1 and interleukin-1 antagonism. , 1991, Blood.

[58]  L. Heston,et al.  Transfection of a rearranged viral DNA fragment, WZhet, stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[59]  R. Sun,et al.  NF-kappaB inhibits gammaherpesvirus lytic replication. , 2003, Journal of virology.

[60]  S. Howell,et al.  KSHV vFLIP binds to IKK-gamma to activate IKK. , 2003, Journal of cell science.

[61]  L. Kirshenbaum,et al.  IKK beta is required for Bcl-2-mediated NF-kappa B activation in ventricular myocytes. , 2002, The Journal of biological chemistry.

[62]  D. Green,et al.  The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. , 2002, Immunity.

[63]  T. Hofmann,et al.  The human papillomavirus oncoprotein E7 attenuates NF-kappa B activation by targeting the Ikappa B kinase complex. , 2002, The Journal of biological chemistry.

[64]  J. Ye,et al.  Regulation of the NF-kappaB activation pathway by isolated domains of FIP3/IKKgamma, a component of the IkappaB-alpha kinase complex. , 2000, The Journal of biological chemistry.

[65]  M. Karin,et al.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. , 2000, Annual review of immunology.

[66]  S P Lawrence,et al.  Advances in the treatment of hepatitis C. , 2000, Advances in internal medicine.

[67]  E. Harhaj,et al.  Domain-specific interaction with the I kappa B kinase (IKK)regulatory subunit IKK gamma is an essential step in tax-mediated activation of IKK. , 2000, The Journal of biological chemistry.

[68]  R. Flavell,et al.  Lymphotoxin-beta-deficient mice show defective antiviral immunity. , 1999, Virology.

[69]  H. Heslop,et al.  Control of virus-induced lymphoproliferation: Epstein-Barr virus-induced lymphoproliferation and host immunity. , 1997, Molecular medicine today.

[70]  T. Chatila,et al.  Cyclosporin A‐sensitive induction of the Epstein‐Barr virus lytic switch is mediated via a novel pathway involving a MEF2 family member , 1997, The EMBO journal.

[71]  P. Latreille,et al.  Copyright © 1997, American Society for Microbiology Complete Sequence and Genomic Analysis of Murine , 1997 .

[72]  E. Kieff Epstein-Barr virus and its replication , 1996 .